About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
This briefing was developed for NICE by Cedar. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality‑assured and approved for publication.
Dr Helen Morgan, Information Specialist, Cedar
Kathleen Withers, Researcher, Cedar
Dr Grace Carolan‑Rees, Director, Cedar
The following specialist commentators provided comments on a draft of this briefing:
Dr Andy Ashton, Consultant in Emergency Medicine, Clinical Director Emergency Department, Whiston Hospital, Merseyside.
Mr Baljit Dheansa, Consultant Plastic Surgeon, Queen Victoria Hospital, Sussex.
Dr John Matthews, Clinical Lead for Cheshire and Mersey Major Trauma Network, Consultant in Emergency Medicine, Whiston Hospital, Merseyside.
Professor Timothy Rainer, Professor of Emergency Medicine, Cardiff and Vale University Health Board, and Honorary Consultant, Cardiff University, Wales.
Dr Andy Ashton is a consultant colleague at the same hospital as Rowan Pritchard Jones, the developer of Mersey Burns. They have collaborated on some IT projects.
Mr Baljit Dheansa is a member of the national burns clinical reference group, a member of the South East Burns Operational Delivery Network, Clinical Advisor to Blond McIndoe Research Foundation and private practice in plastic surgery.
© National Institute for Health and Care Excellence, 2016. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.